These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 23117744

  • 1. Who benefits from statins? Patient or focal plaque?
    Fujii K, Masuyama T.
    Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744
    [No Abstract] [Full Text] [Related]

  • 2. Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
    Takashima H, Ozaki Y, Morimoto T, Kimura T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Daida H, Mizuno T, Asai K, Kuroda Y, Kosaka T, Kuhara Y, Kurita A, Maeda K, Amano T, Matsuzaki M, JAPAN-ACS Investigators.
    Circ J; 2012; 76(12):2840-7. PubMed ID: 22972364
    [Abstract] [Full Text] [Related]

  • 3. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K.
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract] [Full Text] [Related]

  • 4. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T, Ota H, Hasebe N.
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Torcetrapib and atorvastatin.
    Shear CL.
    N Engl J Med; 2005 Oct 06; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
    [No Abstract] [Full Text] [Related]

  • 8. Noninferiority of pitavastatin in intravascular ultrasound findings.
    Kaneda H, Ma J, Morita T.
    J Am Coll Cardiol; 2010 Jan 19; 55(3):262-3; author reply 263. PubMed ID: 20117416
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
    Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M, JAPAN-ACS Investigators.
    J Atheroscler Thromb; 2010 Oct 27; 17(10):1096-107. PubMed ID: 20675955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
    Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K.
    Coron Artery Dis; 2012 Aug 27; 23(5):315-21. PubMed ID: 22617341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beyond greyscale IVUS assessment of progression/regression: it should be simple, but it's not.
    Mintz GS.
    Eur Heart J Cardiovasc Imaging; 2014 Apr 27; 15(4):378-9. PubMed ID: 24448226
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.